Literature DB >> 8034615

Characterization of the ligand binding domain of human retinoid X receptor alpha expressed in Escherichia coli.

L Cheng1, A W Norris, B F Tate, M Rosenberger, J F Grippo, E Li.   

Abstract

In order to study the structural details of ligand protein interactions of the human retinoid X receptor alpha (hRXR alpha), the DEF and EF domains of the receptor were expressed as glutathione S-transferase (GST) fusion proteins in Escherichia coli. The fusion proteins were expressed at high levels and were affinity-purified by chromatography over glutathione-agarose. The DEF and EF domains were cleaved from the fusion proteins by digestion with thrombin. Retinoic acid binding was quantitated using two different methods. The apparent dissociation constant (Kd) and the stoichiometry of 9-cis-retinoic acid binding were performed by monitoring quenching of protein fluorescence. To directly compare the binding affinity of the E. coli-derived truncated hRXR alpha with full-length hRXR alpha expressed in transiently transfected COS cells, Scatchard analyses of [3H]9-cis-retinoic acid binding assays were performed. Both methods of analysis indicate that while the cleaved DEF peptide bound 9-cis-retinoic acid tightly, the cleaved EF peptide exhibited variable binding activity between preparations. By fluorimetric analysis, the Kd of the cleaved DEF peptide was estimated to be 3 +/- 0.5 nM with a stoichiometry of 1:1.1 +/- 0.1. By Scatchard analysis, the Kd values for [3H]9-cis-retinoic acid to the GST-hRXR alpha (DEF) peptide and the cleaved DEF peptide were estimated to be 1.8 nM and 5.6 nM, respectively. The estimated molecular mass from high speed sedimentation equilibrium experiments was 36 +/- 2 kDa for the apo-DEF peptide alone and 38 +/- 3 kDa for the holo-DEF peptide complexed with 9-cis-retinoic acid. This suggests that the recombinant ligand binding domain was predominantly in the monomer form. However, dimers of the cleaved DEF peptides were detected in chemical cross-linking experiments both in the presence and absence of 9-cis-retinoic acid. Since the purified E. coli-derived truncated hRXR alpha DEF peptide appears to fully retain its ligand binding activity, it should provide a useful model system for further structural analysis of ligand-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034615

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Coexpression of nuclear receptor partners increases their solubility and biological activities.

Authors:  C Li; J W Schwabe; E Banayo; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

2.  Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.

Authors:  Anil Desphande; Gang Xia; LeeAnn J Boerma; Kimberly K Vines; Venkatram R Atigadda; Susan Lobo-Ruppert; Clinton J Grubbs; Fariba L Moeinpour; Craig D Smith; Konstantin Christov; Wayne J Brouillette; Donald D Muccio
Journal:  Bioorg Med Chem       Date:  2013-12-01       Impact factor: 3.641

3.  Increased Molecular Flexibility Widens the Gap between K i and K d values in Screening for Retinoid X Receptor Modulators.

Authors:  Masaki Watanabe; Mariko Nakamura-Nakayama; Michiko Fujihara; Mayu Kawasaki; Shogo Nakano; Hiroki Kakuta
Journal:  ACS Med Chem Lett       Date:  2022-01-21       Impact factor: 4.345

4.  Effect of heterodimer partner RXRalpha on PPARgamma activation function-2 helix in solution.

Authors:  Jianyun Lu; Minghe Chen; Susan E Stanley; Ellen Li
Journal:  Biochem Biophys Res Commun       Date:  2007-10-31       Impact factor: 3.575

5.  Locust retinoid X receptors: 9-Cis-retinoic acid in embryos from a primitive insect.

Authors:  Shaun M Nowickyj; James V Chithalen; Don Cameron; Michael G Tyshenko; Martin Petkovich; Gerard R Wyatt; Glenville Jones; Virginia K Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

6.  Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.

Authors:  Venkatram R Atigadda; Gang Xia; Anil Deshpande; Lizhi Wu; Natalia Kedishvili; Craig D Smith; Helen Krontiras; Kirby I Bland; Clinton J Grubbs; Wayne J Brouillette; Donald D Muccio
Journal:  J Med Chem       Date:  2015-09-22       Impact factor: 7.446

7.  The effect of antagonists on the conformational exchange of the retinoid X receptor alpha ligand-binding domain.

Authors:  Jianyun Lu; Marcia I Dawson; Qiong Ying Hu; Zebin Xia; Jesse D Dambacher; Mao Ye; Xiao-Kun Zhang; Ellen Li
Journal:  Magn Reson Chem       Date:  2009-12       Impact factor: 2.447

8.  Retinoid X receptor alpha forms tetramers in solution.

Authors:  S Kersten; D Kelleher; P Chambon; H Gronemeyer; N Noy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Creation of Fluorescent RXR Antagonists Based on CBTF-EE and Application to a Fluorescence Polarization Binding Assay.

Authors:  Maho Takioku; Yuta Takamura; Michiko Fujihara; Masaki Watanabe; Shoya Yamada; Mayu Kawasaki; Sohei Ito; Shogo Nakano; Hiroki Kakuta
Journal:  ACS Med Chem Lett       Date:  2021-05-07       Impact factor: 4.632

10.  Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.

Authors:  Venkatram R Atigadda; Gang Xia; Anil Desphande; LeeAnn J Boerma; Susan Lobo-Ruppert; Clinton J Grubbs; Craig D Smith; Wayne J Brouillette; Donald D Muccio
Journal:  J Med Chem       Date:  2014-06-05       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.